Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training
July 21, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK – 21 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways to participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit
July 07, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK, July 07, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
July 05, 2021 06:00 ET
|
COMPASS Pathfinder Ltd.
London, UK – 5 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
June 30, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
London, UK – 30 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
June 23, 2021 07:00 ET
|
COMPASS Pathfinder Ltd.
Programme aims to support students from under-represented ethnic groups London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
COMPASS Pathways announces pricing of public offering
April 29, 2021 20:45 ET
|
COMPASS Pathfinder Ltd.
London, UK, 30 April 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based...
COMPASS Pathways launches proposed public offering
April 27, 2021 17:22 ET
|
COMPASS Pathfinder Ltd.
London, UK, April 27, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
April 15, 2021 03:00 ET
|
COMPASS Pathfinder Ltd.
London, UK, April 15, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
April 01, 2021 07:01 ET
|
COMPASS Pathfinder Ltd.
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors London, UK – 1 April 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated...
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
February 09, 2021 07:02 ET
|
Compass Pathways
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic...